- Filed
- May 11, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · Apr 30, 2026 | 14.98M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 15.04M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 10.74M sh |
| Stock Repurchased | Q1 2026 · Mar 31, 2026 | $1.44M |
| Stock Repurchased | Q1 2026 · Mar 31, 2025 | $2.06M |
| Dividends Paid | Q1 2026 · Mar 31, 2026 | $4.34M |
| Dividends Paid | Q1 2026 · Mar 31, 2025 | $4.19M |
| Capex | Q1 2026 · Mar 31, 2026 | $1.52M |
| Capex | Q1 2026 · Mar 31, 2025 | $835K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$177K |
| Operating Cash Flow restated | Q1 2026 · Mar 31, 2025 | −$9.39M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $84.22M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $87.99M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $470M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $465.35M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $427.07M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $260.42M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $3.92B |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $3.95B |
| Total Assets | Q1 2026 · Mar 31, 2026 | $4.39B |
| Total Assets | Q1 2026 · Dec 31, 2025 | $4.41B |
| Total Assets | Q1 2026 · Mar 31, 2025 | $4.31B |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $0.91 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$1.29 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | $0.91 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$1.30 |
| Net Income | Q1 2026 · Mar 31, 2026 | $13.7M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$13.91M |
| Revenue | Q1 2026 · Mar 31, 2026 | $59.09M |
| Revenue | Q1 2026 · Mar 31, 2025 | $44.88M |